- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05397639
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Masupirdine (SUVN-502) for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a multicenter, randomized, double-blind, placebo-controlled study, consisting of 12 weeks of treatment.
Approximately 375 participants will be enrolled at approximately 50 centers worldwide.
Study medication will be administered orally once-daily from Day 1 through Day 85. Screening will occur within approximately 4 weeks prior to randomization. Following screening procedures for assessment of inclusion and exclusion criteria, eligible participants will be randomized into the study.
Study Type
Enrollment (Estimated)
Phase
- Phase 3
Contacts and Locations
Study Contact
- Name: Study Contact
- Phone Number: +9140 2319 3956
- Email: agitation@suven.com
Study Locations
-
-
-
Rijeka, Croatia, 51000
- Recruiting
- Clinical Hospital Center Rijeka
-
Contact:
- Clinical Research Site
-
Zagreb, Croatia, 10000
- Recruiting
- Polyclinic Neuron
-
Contact:
- Clinical Research Site
-
Zagreb, Croatia, 10000
- Recruiting
- University Hospital Center Zagreb
-
Contact:
- Clinical Research Site
-
Zagreb, Croatia, 10090
- Recruiting
- Klinika za psihijatriju Sveti Ivan
-
Contact:
- Clinical Research Site
-
Zagreb, Croatia, 10090
- Recruiting
- Klinika za psihijatriju Vrapce
-
Contact:
- Clinical Research Site
-
-
-
-
Dolnoslaskie
-
Wrocław, Dolnoslaskie, Poland, 50-220
- Recruiting
- EMC Instytut Medyczny S.A.
-
Contact:
- Clinical Research Site
-
-
Lubelskie
-
Lublin, Lubelskie, Poland, 20-078
- Recruiting
- Clinical Best Solutions - Lublin
-
Contact:
- Clinical Research Site
-
-
Lódzkie
-
Łódź, Lódzkie, Poland, 90-349
- Recruiting
- Osrodek Badan Klinicznych Appletreeclinics
-
Contact:
- Clinical Research Site
-
Łódź, Lódzkie, Poland, 93-118
- Recruiting
- Medycyna Milorzab sp. z o.o.
-
Contact:
- Clinical Research Site
-
-
Malopolskie
-
Kraków, Malopolskie, Poland, 31-505
- Recruiting
- Krakowska Akademia Neurologii Sp. z o.o.
-
Contact:
- Clinical Research Site
-
-
Mazowieckie
-
Warszawa, Mazowieckie, Poland, 00-215
- Recruiting
- FutureMeds Warszawa Centrum
-
Contact:
- Clinical Research Site
-
-
Slaskie
-
Katowice, Slaskie, Poland, 40-282
- Recruiting
- Centrum Medyczne Silmedic Sp z o o
-
Contact:
- Clinical Research Site
-
Katowice, Slaskie, Poland, 40-650
- Recruiting
- Novo-Med Zielinski i wsp. Sp.J.
-
Contact:
- Clinical Research Site
-
Katowice, Slaskie, Poland, 40-686
- Recruiting
- Neuro-Medic Janusz Zbrojkiewicz
-
Contact:
- Clinical Research Site
-
-
-
-
-
Belgrade, Serbia, 11000
- Recruiting
- Clinical Hospital Center Dragisa Misovic Dedinje
-
Contact:
- Clinical Research Site
-
Belgrade, Serbia, 11000
- Recruiting
- University Clinical Center of Serbia, Clinic for Neurology
-
Contact:
- Clinical Research Site
-
Belgrade, Serbia, 11000
- Recruiting
- Military Medical Academy, Clinic of Neurology
-
Contact:
- Clinical Research Site
-
Kovin, Serbia, 26220
- Recruiting
- Special Hospital for Psychiatric Diseases
-
Contact:
- Clinical Research Site
-
Kragujevac, Serbia, 34000
- Recruiting
- University Clinical Center Kragujevac, Clinic for Psychiatry
-
Contact:
- Clinical Research Site
-
Niš, Serbia, 18000
- Recruiting
- University Clinical Center Nis, Clinic for neurology
-
Contact:
- Clinical Research Site
-
Novi Sad, Serbia, 21000
- Recruiting
- Clinical Centre of Vojvodina, Clinic of Neurology
-
Contact:
- Clinical Research Site
-
Vršac, Serbia, 26300
- Recruiting
- Special Hospital for Psychiatric Diseases ''Dr Slavoljub Bakalovic''
-
Contact:
- Clinical Research Site
-
-
-
-
California
-
Anaheim, California, United States, 92805-5854
- Recruiting
- Advanced Research Center, Inc.
-
Contact:
- Clinical Research Site
-
Costa Mesa, California, United States, 92626-4607
- Recruiting
- ATP Clinical Research, Inc.
-
Contact:
- Clinical Research Site
-
Fresno, California, United States, 93710-5473
- Recruiting
- Neuro Pain Medical Center
-
Contact:
- Clinical Research Site
-
Fullerton, California, United States, 92835-1040
- Recruiting
- Neurology Center of North Orange County
-
Contact:
- Clinical Research Site
-
Los Angeles, California, United States, 90095
- Recruiting
- Mary S Easton Center for Alzheimer's Research and Care UCLA
-
Contact:
- Clinical Research Site
-
-
Connecticut
-
Stamford, Connecticut, United States, 06905
- Recruiting
- Ki Health Partners, LLC
-
Contact:
- Clinical Research Site
-
-
Florida
-
Miami, Florida, United States, 33122-1335
- Recruiting
- Central Miami Medical Institute
-
Contact:
- Clinical Research Site
-
Miami, Florida, United States, 33125-2607
- Recruiting
- Allied Biomedical Research Institute
-
Contact:
- Clinical Research Site
-
Miami, Florida, United States, 33133
- Recruiting
- CCM Clinical Research Group
-
Contact:
- Clinical Research Site
-
Miami, Florida, United States, 33143
- Recruiting
- Novel Clinical Research Center, LLC.
-
Contact:
- Clinical Research Site
-
Miami, Florida, United States, 33176
- Recruiting
- Brainstorm Research
-
Contact:
- Clinical Research Site
-
Miami, Florida, United States, 33137
- Recruiting
- Miami Jewish Health
-
Contact:
- Clinical Research Site
-
Orlando, Florida, United States, 32807
- Recruiting
- Combined Research Orlando Phase I-IV
-
Contact:
- Clinical Research Site
-
Pompano Beach, Florida, United States, 33064
- Recruiting
- Quantum Laboratories Inc
-
Contact:
- Clinical Research Site
-
-
New York
-
Amherst, New York, United States, 14226
- Recruiting
- Dent Neurologic Institute
-
Contact:
- Clinical Research Site
-
Commack, New York, United States, 11725-2808
- Recruiting
- North Suffolk Neurology
-
Contact:
- Clinical Research Site
-
New Windsor, New York, United States, 12553
- Recruiting
- Mid Hudson Medical Research, PLLC
-
Contact:
- Clinical Research Site
-
Staten Island, New York, United States, 10312-6501
- Recruiting
- Richmond Behavioral Associates
-
Contact:
- Clinical Research Site
-
-
Ohio
-
Canton, Ohio, United States, 44718
- Recruiting
- NeuroScience Research Center, LLC
-
Contact:
- Clinical Research Site
-
-
South Carolina
-
Charleston, South Carolina, United States, 29401-1113
- Recruiting
- Ralph H. Johnson VA Health Care System
-
Contact:
- Clinical Research Site
-
-
Texas
-
Houston, Texas, United States, 77074
- Recruiting
- Clinical Trial Network
-
Contact:
- Clinical Research Site
-
Houston, Texas, United States, 77030-4202
- Recruiting
- Baylor College of Medicine
-
Contact:
- Clinical Research Site
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Has a diagnosis of dementia of the Alzheimer's type according to the National Institute on Aging-Alzheimer's Association (NIA-AA) criteria.
- Has confirmed agitation using the IPA Consensus Provisional Definition of Agitation in Cognitive Disorders.
- Has a score between 8 and 24 (both inclusive) on Mini-Mental State Examination (MMSE).
Exclusion Criteria:
- Participants with dementia predominantly of the non-Alzheimer's type (e.g., vascular dementia, parkinson's disease, lewy body disease, frontotemporal dementia)
- Has symptoms of agitation that are not secondary to Alzheimer's disease (eg, pain, other psychiatric disorder, or delirium due to a metabolic disorder, systemic infection, or substance-induced).
- Participant (or caregiver) is deemed otherwise ineligible for participation in this study in the investigator's judgement.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Low Dose Masupirdine Arm
Tablet
|
Tablet, Once Daily
Other Names:
|
Experimental: High Dose Masupirdine Arm
Tablet
|
Tablet, Once Daily
Other Names:
|
Placebo Comparator: Placebo
Tablet
|
Matching Placebo Tablet, Once Daily
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cohen-Mansfield Agitation Inventory (CMAI)
Time Frame: From Baseline to Week 12 visit
|
Change in CMAI items score aligning to the International Psychogeriatric Association (IPA) agitation criteria domains (physical aggression, excessive motor activity, and verbal aggression).
CMAI is a validated 29-item questionnaire to assess agitation.
Each item is rated on a 7-point scale ranging from 1 "Never" to 7 "Several times per hour".
Higher scores indicate worsening agitation.
|
From Baseline to Week 12 visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Modified Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (mADCS-CGI-C)
Time Frame: From Baseline to Week 12 visit
|
Change in mADCS-CGI-C.
The mADCS-CGI-C is a modification of the ADCS-CGI-C instrument that focuses specifically on agitation.
It is a 7-point Likert scale that ranges from marked improvement scored as 1 to marked worsening scored as 7.
The range is from 1 to 7. Higher scores indicate worsening agitation.
|
From Baseline to Week 12 visit
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Neurocognitive Disorders
- Neurodegenerative Diseases
- Dyskinesias
- Psychomotor Disorders
- Tauopathies
- Psychomotor Agitation
- Dementia
- Alzheimer Disease
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Serotonin Agents
- Serotonin Antagonists
- 1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate
Other Study ID Numbers
- CTP3S1502HT6
- 2021-003405-22 (EudraCT Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Agitation
-
University Hospital, GrenobleFondation ApicilCompletedAgitation,PsychomotorFrance
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingAgitation,PsychomotorNetherlands
-
Impel PharmaceuticalsCompleted
-
Hennepin Healthcare Research InstituteCompletedAgitation,PsychomotorUnited States
-
BioXcel Therapeutics IncCognitive Research CorporationCompletedBipolar Disorder | Agitation,Psychomotor | Agitation Associated With Bipolar DisorderUnited States
-
Bionomics LimitedCompleted
-
Prince of Songkla UniversityCompletedEmergence Agitation, Post Operative Behavioral ChangesThailand
-
Istanbul Medeniyet UniversityUnknownAgitation on Recovery From Sedation
-
Tehran University of Medical SciencesCompletedKetamine Induced AgitationIran, Islamic Republic of
-
Seoul National University Bundang HospitalCompletedAgitation,PsychomotorKorea, Republic of
Clinical Trials on Masupirdine 50 mg
-
Zydus Lifesciences LimitedRecruitingAmyotrophic Lateral SclerosisIndia
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsCompletedInfection, Human Immunodeficiency VirusUnited States
-
Alcon ResearchCompletedNeovascular Age-Related Macular Degeneration
-
Sprout Pharmaceuticals, IncCompletedSexual Dysfunctions, PsychologicalAustria, Belgium, Czech Republic, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom
-
Eisai Korea Inc.RecruitingParkinson DiseaseKorea, Republic of
-
Idorsia Pharmaceuticals Ltd.CompletedInsomnia DisorderUnited States, Germany, Australia, Canada, Denmark, Italy, Poland, Serbia, Spain, Switzerland
-
CymaBay Therapeutics, Inc.CompletedHomozygous Familial HypercholesterolemiaCanada, France, Netherlands, Norway
-
Tourmaline Bio, Inc.RecruitingThyroid Eye DiseaseUnited States, Jordan
-
GlaxoSmithKlineCompletedGastroparesisAustralia
-
PfizerCompletedHealthy VolunteerNetherlands